Sanofi American Depositary Shares (Each representing one-half of
SNY Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Recent trades of SNY by members of U.S. Congress
SNY Stock Insider Trading Activity
Follow @QuiverQuant for major insider updates
---
Closing Price
Purchase
Sale
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
SNY Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
SNY Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in SNY holdings by institutional investors
Quarterly net insider trading by SNY's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Backtest Start Date
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Subscribe to Quiver Premium for insider trading alerts
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$1,250,000 Oct 20, 2026 Issue: Manufacturing Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$920,000 Jul 20, 2026 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Manufacturing
-
$2,580,000 Apr 20, 2026 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Manufacturing
-
$1,100,000 Jan 20, 2026 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Manufacturing
-
$1,590,000 Oct 20, 2025 Issue: Manufacturing Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$1,050,000 Jul 21, 2025 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark Manufacturing
-
$2,540,000 Apr 21, 2025 Issue: Manufacturing Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$690,000 Jan 21, 2025 Issue: Manufacturing Health Issues Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$1,815,000 Oct 21, 2024 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$860,000 Jul 22, 2024 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$60,000 Feb 08, 2024 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Budget/Appropriations Health Issues Medicare/Medicaid
-
$880,000 Jan 22, 2024 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$1,520,000 Oct 18, 2023 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$1,870,000 Apr 20, 2022 Issue: Manufacturing Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid Health Issues
-
$850,000 Jan 20, 2022 Issue: None
-
$1,310,000 Oct 20, 2021 Issue: None
-
$980,000 Jul 21, 2021 Issue: None
-
$1,440,000 Apr 20, 2021 Issue: None
-
$700,000 Jan 20, 2021 Issue: None
-
$1,300,000 Oct 20, 2020 Issue: None
-
$860,000 Jul 20, 2020 Issue: None
-
$1,750,000 Apr 20, 2020 Issue: None
-
$783,000 Jan 21, 2020 Issue: None
-
$40,000 Jul 10, 2019 Issue: Pharmacy Copyright/Patent/Trademark
-
$1,668,000 Apr 22, 2019 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Budget/Appropriations Torts
-
$790,000 Jan 22, 2019 Issue: Torts Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$1,100,000 Jul 20, 2018 Issue: Health Issues Economics/Economic Development Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid
-
$2,030,000 Apr 20, 2018 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$600,000 Jan 22, 2018 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$1,260,000 Oct 20, 2017 Issue: Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$740,000 Jul 20, 2017 Issue: Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Trade (domestic/foreign) Torts Taxation/Internal Revenue Code
-
$1,896,000 Apr 20, 2017 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Consumer Issues/Safety/Products Pharmacy Torts Medicare/Medicaid
-
$470,000 Jan 20, 2017 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Pharmacy Taxation/Internal Revenue Code
-
$31,000 Apr 02, 2016 Issue: Medical/Disease Research/Clinical Labs Homeland Security Health Issues
-
$990,000 Jan 11, 2016 Issue: Torts Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Animals Pharmacy Trade (domestic/foreign)
-
$940,000 Jan 05, 2016 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Economics/Economic Development Animals Medical/Disease Research/Clinical Labs Pharmacy
-
$1,170,000 Oct 14, 2015 Issue: Pharmacy Animals Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Economics/Economic Development
-
$840,000 Jul 17, 2015 Issue: Pharmacy Animals Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Economics/Economic Development
-
$1,370,000 Apr 16, 2015 Issue: Animals Medicare/Medicaid Health Issues Economics/Economic Development Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark Pharmacy
-
$840,000 Jan 16, 2015 Issue: Pharmacy Animals Medicare/Medicaid Health Issues Economics/Economic Development Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$940,000 Oct 16, 2014 Issue: Pharmacy Animals Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Economics/Economic Development Medical/Disease Research/Clinical Labs
-
$720,000 Jul 09, 2014 Issue: Animals Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Economics/Economic Development Copyright/Patent/Trademark Pharmacy
-
$1,570,000 Apr 17, 2014 Issue: Pharmacy Animals Budget/Appropriations Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$790,000 Jan 20, 2014 Issue: Animals Budget/Appropriations Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Manufacturing Torts
-
$1,310,000 Oct 15, 2013 Issue: Animals Medicare/Medicaid Health Issues Economics/Economic Development Taxation/Internal Revenue Code Manufacturing Copyright/Patent/Trademark
-
$800,000 Oct 15, 2013 Issue: Animals Medicare/Medicaid Health Issues Economics/Economic Development Copyright/Patent/Trademark Taxation/Internal Revenue Code Manufacturing
-
$1,590,000 Aug 13, 2013 Issue: Medical/Disease Research/Clinical Labs Animals Medicare/Medicaid Health Issues Economics/Economic Development Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$1,800,000 Jul 18, 2013 Issue: Animals Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Economics/Economic Development
-
$710,000 Oct 15, 2012 Issue: Health Issues Economics/Economic Development Taxation/Internal Revenue Code Animals Medicare/Medicaid
-
$1,420,000 Jul 19, 2012 Issue: Medical/Disease Research/Clinical Labs Animals Health Issues Taxation/Internal Revenue Code Manufacturing Copyright/Patent/Trademark Economics/Economic Development
-
$750,000 Apr 16, 2012 Issue: Torts Animals Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Manufacturing Copyright/Patent/Trademark Medical/Disease Research/Clinical Labs
-
$710,000 Jan 17, 2012 Issue: Torts Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code
-
$1,100,000 Oct 20, 2011 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medical/Disease Research/Clinical Labs Torts Medicare/Medicaid
-
$930,000 Jul 19, 2011 Issue: Torts Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$1,860,000 Apr 20, 2011 Issue: Torts Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$623,000 Mar 16, 2011 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$950,000 Jan 20, 2011 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid
-
$1,380,000 Oct 18, 2010 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid
-
$620,000 Oct 13, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$870,000 Jul 19, 2010 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Pharmacy
-
$630,000 Jul 16, 2010 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
-
$1,580,000 Apr 20, 2010 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Pharmacy
-
$920,000 Apr 20, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,430,000 Jan 20, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Pharmacy
-
$608,000 Jan 19, 2010 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,470,000 Oct 19, 2009 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Pharmacy Copyright/Patent/Trademark
-
$593,000 Oct 08, 2009 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,580,000 Jul 17, 2009 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Pharmacy
-
$633,000 Jul 13, 2009 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,460,000 Apr 20, 2009 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues Pharmacy
-
$578,000 Apr 15, 2009 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,160,000 Jan 21, 2009 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$594,000 Jan 14, 2009 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$1,270,000 Dec 18, 2008 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Medicare/Medicaid
-
$1,480,000 Dec 18, 2008 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Medicare/Medicaid
-
$1,190,000 Dec 18, 2008 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Environment/Superfund Copyright/Patent/Trademark
-
$565,000 Oct 17, 2008 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$460,000 Jul 21, 2008 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Copyright/Patent/Trademark
-
$440,000 Apr 18, 2008 Issue: Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$650,000 Feb 14, 2008 Issue: Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$3,560,000 Feb 11, 2008 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Veterans Defense Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Budget/Appropriations
-
$650,000 Aug 14, 2007 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$3,560,000 Aug 13, 2007 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Veterans Financial Institutions/Investments/Securities Defense Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$3,674,234 Feb 13, 2007 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Financial Institutions/Investments/Securities
-
$600,000 Feb 01, 2007 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$2,006,189 Aug 17, 2006 Issue: Financial Institutions/Investments/Securities Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Veterans Medicare/Medicaid Pharmacy
-
$500,000 Aug 08, 2006 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$2,380,000 Feb 17, 2006 Issue: Health Issues Medicare/Medicaid Budget/Appropriations Pharmacy Medical/Disease Research/Clinical Labs Torts Copyright/Patent/Trademark
-
$500,000 Feb 14, 2006 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$1,480,699 Aug 29, 2005 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Pharmacy Torts
-
$500,000 Aug 16, 2005 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$1,344,000 Feb 08, 2005 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
-
$500,000 Feb 07, 2005 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$500,000 Aug 19, 2004 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$1,570,000 Aug 12, 2004 Issue: Budget/Appropriations Trade (domestic/foreign) Health Issues Medicare/Medicaid
-
$500,000 Apr 12, 2004 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues
-
$1,270,712 Feb 26, 2004 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations
-
$360,000 Aug 14, 2003 Issue: Taxation/Internal Revenue Code Health Issues Trade (domestic/foreign)
-
$1,300,000 Aug 14, 2003 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Torts
-
$360,000 Feb 14, 2003 Issue: Taxation/Internal Revenue Code Health Issues
Former government officials who have lobbied for SNY
1 former government official at 1 lobbying firm has lobbied for SNY, most recently Jul 20, 2017.
-
Melissa Bartlett House New House Energy and Commerce Committee Counsel
SNY Estimated quarterly lobbying spending
SNY Revenue by Segment or Geography
By Segment
By Geography
SNY Income Statement
SNY Balance Sheet
SNY Cash Flow
U.S. Patents
New SNY patent grants
-
Patent Title: Sodium salt of (r)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1h-imidazol-4-yl)-propionic acid Aug. 11, 2015
-
Patent Title: Derivatives of pyrazole 3,5-carboxylates, their preparation and their application in therapeutics Aug. 11, 2015
-
Patent Title: Pharmaceutical composition comprising a solid dispersion with a polymer matrix containing a continuous polydextrose phase and a continuous phase of a polymer other than polydextrose Jul. 21, 2015
-
Patent Title: Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments Jul. 14, 2015
-
Patent Title: Cyclic peptides, their preparation and their use as inhibitors of the platelet adhesion Jul. 07, 2015
-
Patent Title: Anti-cancer compound and pharmaceutical composition containing the same Jul. 07, 2015
-
Patent Title: Substituted pyrimidone derivatives Jul. 07, 2015
-
Patent Title: Substituted alkyl pyrimidin-4-one derivatives Jul. 07, 2015
-
Patent Title: Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists Jul. 07, 2015
-
Patent Title: Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [ (s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl ]-amide Jun. 30, 2015
-
Patent Title: Anticancer derivatives, preparation thereof and therapeutic use thereof Jun. 16, 2015
-
Patent Title: Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof Jun. 09, 2015
-
Patent Title: 2,5-substituted oxazolopyrimidine derivatives May. 26, 2015
-
Patent Title: Bio-diagnostic testing system and methods May. 19, 2015
-
Patent Title: Indanyl-substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them May. 19, 2015
-
Patent Title: Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals May. 12, 2015
-
Patent Title: 5-oxoisoxazoles as inhibitors of lipases and phospholipases May. 12, 2015
-
Patent Title: Reductive amination process for preparation of dronedarone using amine intermediary compound May. 05, 2015
-
Patent Title: Identifying molecules modulating protein-protein interactions using protease activated reporters May. 05, 2015
-
Patent Title: Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals Apr. 28, 2015
-
Patent Title: Pharmaceutical composition and dosage form comprising dronedarone, and preparation method thereof Apr. 28, 2015
-
Patent Title: Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof Apr. 21, 2015
-
Patent Title: Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application Apr. 07, 2015
-
Patent Title: Benzoic acid salt of otamixaban Mar. 31, 2015
-
Patent Title: (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors Mar. 31, 2015
-
Patent Title: Nitrobenzothiazole derivatives, preparation thereof and therapeutic applications thereof Mar. 31, 2015
-
Patent Title: Methods of use for antibodies that specifically bind to the epha2 receptor Mar. 31, 2015
-
Patent Title: Transgenic non-human animal and uses thereof Mar. 17, 2015
-
Patent Title: Cxcr2 inhibitors Mar. 17, 2015
-
Patent Title: Humanized anti-cxcr5 antibodies, derivatives thereof and their use Mar. 17, 2015
-
Patent Title: Inhaler for powdery substances, in particular medicinal substances Mar. 17, 2015
-
Patent Title: Anti-alpha2 integrin antibodies and their uses Mar. 10, 2015
-
Patent Title: 5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as camkii kinase inhibitors for treating cardiovascular diseases Mar. 10, 2015
-
Patent Title: Process for synthesizing keto benzofuran derivatives Feb. 24, 2015
-
Patent Title: Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals Feb. 24, 2015
-
Patent Title: (heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors Feb. 17, 2015
-
Patent Title: Conjugates, preparation thereof, and therapeutic use thereof Feb. 10, 2015
-
Patent Title: Process for the preparation of 3-(6-amino-pyridin-3yl)-2-acrylic acid derivatives Jan. 27, 2015
-
Patent Title: Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases Jan. 13, 2015
-
Patent Title: Azole derivatives in the form of lipase and phospholipase inhibitors Dec. 30, 2014
-
Patent Title: Dosing device Dec. 23, 2014
-
Patent Title: Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals Dec. 16, 2014
-
Patent Title: Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof Dec. 16, 2014
-
Patent Title: Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring Dec. 09, 2014
-
Patent Title: (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors Dec. 09, 2014
-
Patent Title: Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof Dec. 02, 2014
-
Patent Title: Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof Nov. 25, 2014
-
Patent Title: Process for the preparation of dronedarone Nov. 18, 2014
-
Patent Title: Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof Nov. 18, 2014
-
Patent Title: Process for preparing aminobenzoylbenzofuran derivatives Nov. 11, 2014
Government Contracts
Federal grants, loans, and purchases
- $6,018,839 2026-09-21 00:00:00 Agency: Department of Health and Human Services
- $1,932 2026-09-21 00:00:00 Agency: Department of Veterans Affairs
- $68,964 2026-09-17 00:00:00 Agency: Department of State
- $1,961 2026-08-27 00:00:00 Agency: Department of Justice
- $28,096 2026-07-30 00:00:00 Agency: Department of Health and Human Services
- $5,604 2026-07-07 00:00:00 Agency: Department of Justice
- $2,000,000 2026-06-11 00:00:00 Agency: Department of Health and Human Services
- $1,271 2026-06-09 00:00:00 Agency: Department of Justice
- $1,515,041 2026-06-08 00:00:00 Agency: Department of Health and Human Services
- $8,317 2026-05-28 00:00:00 Agency: Department of Health and Human Services
- $7,841 2026-05-28 00:00:00 Agency: Department of Health and Human Services
- $2,802 2026-05-21 00:00:00 Agency: Department of Justice
- $1,271 2026-05-14 00:00:00 Agency: Department of Justice
- $697,439 2026-05-08 00:00:00 Agency: Department of Health and Human Services
- $2,242 2026-05-06 00:00:00 Agency: Department of Justice
- $2,466 2026-05-01 00:00:00 Agency: Department of Justice
- $1,960 2026-04-28 00:00:00 Agency: Department of Justice
- $482 2026-04-28 00:00:00 Agency: Department of Justice
- $635 2026-04-28 00:00:00 Agency: Department of Justice
- $2,542 2026-04-24 00:00:00 Agency: Department of Justice
- $1,289 2026-04-23 00:00:00 Agency: Department of Justice
- $1,121 2026-04-23 00:00:00 Agency: Department of Justice
- $1,401 2026-04-21 00:00:00 Agency: Department of Justice
- $392 2026-04-21 00:00:00 Agency: Department of Justice
- $2,242 2026-04-21 00:00:00 Agency: Department of Justice
- $560 2026-04-16 00:00:00 Agency: Department of Justice
- $1,457 2026-04-15 00:00:00 Agency: Department of Justice
- $1,271 2026-04-15 00:00:00 Agency: Department of Justice
- $224 2026-04-15 00:00:00 Agency: Department of Justice
- $1,271 2026-04-15 00:00:00 Agency: Department of Justice
- $24,097 2026-04-14 00:00:00 Agency: Department of Veterans Affairs
- $3,082 2026-04-14 00:00:00 Agency: Department of Justice
- $2,242 2026-04-14 00:00:00 Agency: Department of Justice
- $2,242 2026-04-14 00:00:00 Agency: Department of Justice
- $560 2026-04-14 00:00:00 Agency: Department of Justice
- $953 2026-04-14 00:00:00 Agency: Department of Justice
- $1,793 2026-04-14 00:00:00 Agency: Department of Justice
- $3,177 2026-04-14 00:00:00 Agency: Department of Justice
- $2,148 2026-04-14 00:00:00 Agency: Department of Justice
- $3,979 2026-04-14 00:00:00 Agency: Department of Justice
- $3,082 2026-04-13 00:00:00 Agency: Department of Justice
- $3,362 2026-04-13 00:00:00 Agency: Department of Justice
- $467 2026-04-10 00:00:00 Agency: Department of Justice
- $336 2026-04-10 00:00:00 Agency: Department of Justice
- $560 2026-04-10 00:00:00 Agency: Department of Justice
- $3,362 2026-04-10 00:00:00 Agency: Department of Justice
- $2,130 2026-04-10 00:00:00 Agency: Department of Justice
- $1,009 2026-04-10 00:00:00 Agency: Department of Justice
- $336 2026-04-09 00:00:00 Agency: Department of Justice
- $2,522 2026-04-09 00:00:00 Agency: Department of Justice
Government Contracts
Estimated quarterly amount awarded to SNY from public contracts
SNY News
Recent insights relating to SNY
CNBC Recommendations
Recent picks made for SNY stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SNY
SNY Analyst Ratings
SNY Stock Forecasts
...
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
SNY Analyst Forecasts
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
Frequently Asked Questions
- Is $SNY stock a Buy, Sell, or Hold?
- What is the price target for $SNY stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
SNY Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
Frequently Asked Questions
- Who owns $SNY stock?
- Who owns the most shares of $SNY stock?
- What funds own $SNY stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
SNY Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SNY Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
About SNY
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Sanofi American Depositary Shares (Each representing one-half of (SNY) Historical Stock Prices
Daily open, high, low, close, adjusted close and volume for Sanofi American Depositary Shares (Each representing one-half of (SNY).
See every congressional and insider trade on the SNY price chart
Quiver Premium charts SNY's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
Need daily prices for every ticker, in code?
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver API
Sanofi American Depositary Shares (Each representing one-half of Executive Compensation
We estimate that -- received a compensation of -- in --, making them the highest paid executive at SNY, per a recent SEC DEF 14A filing.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|